U.S. pharma large copyright scrapped two experimental weight loss drugs final year—a when-daily tablet, lotiglipron, on account of elevated liver enzymes in addition to a two times-daily tablet, danuglipron, due to potent Uncomfortable side effects—but CEO Albert Bourla has mentioned the company is determined to “play and get” within the ob… Read More